The etiopathogenesis of atopic dermatitis: barrier disruption, immunological derangement, and pruritus
Open accessThe DOI matches its Crossref record; 215 of the 215 references it cites were found in a registry or an index.
Abstract
Atopic dermatitis (AD) is a common chronic skin inflammatory disorder characterized by recurrent eczema accompanied by an intractable itch that leads to an impaired quality of life. Extensive recent studies have shed light on the multifaceted pathogenesis of the disease. The complex interplay among skin barrier deficiency, immunological derangement, and pruritus contributes to the development, progression, and chronicity of the disease. Abnormalities in filaggrin, other stratum corneum constituents, and tight junctions induce and/or promote skin inflammation. This inflammation, in turn, can further deteriorate the barrier function by downregulating a myriad of essential barrier-maintaining molecules. Pruritus in AD, which may be due to hyperinnervation of the epidermis, increases pruritogens, and central sensitization compromises the skin integrity and promotes inflammation. There are unmet needs in the treatment of AD. Based on the detailed evidence available to date, certain disease mechanisms can be chosen as treatment targets. Numerous clinical trials of biological agents are currently being conducted and are expected to provide treatments for patients suffering from AD in the future. This review summarizes the etiopathogenesis of the disease and provides a rationale for choosing the novel targeted therapy that will be available in the future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pattern Recognition Receptors and Inflammation
Takeuchi, O., & Akira, S. (2010) · Cell · doi:10.1016/j.cell.2010.01.022 · Cited by 8,895 · cited 1×
“aureus can worsen barrier impairment [143]; releases proteases, enzymes, and cytolytic toxins that induce cell injuries [143, 144]; and engages PRRs and exerts inflammation [145].”
BackgroundWilliams, H. C., Leung, D. Y. M., Thestrup‐Pedersen, K., & David, T. J. (2000) · Cited by 4,599
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y.-H., Wang, Y., Hood, L., Zhu, Z., Tian, Q., et al. (2005) · Nature Immunology · doi:10.1038/ni1261 · Cited by 4,265 · cited 1×
“expression, which are responsible for eosinophil- and neutrophil-mediated inflammation [109, 110].”
BackgroundAtopic Dermatitis: Global Epidemiology and Risk Factors
Nutten, S. (2015) · Annals of Nutrition and Metabolism · doi:10.1159/000370220 · Cited by 3,055
Palmer, C. N. A., Irvine, A. D., Terron-Kwiatkowski, A., Zhao, Y., Liao, H., Lee, S. P., Goudie, D. R., Sandilands, A., Campbell, L. E., Smith, F. J. D., et al. (2006) · Nature Genetics · doi:10.1038/ng1767 · Cited by 2,978 · cited 1×
“FLG is known to be decreased in the epidermis of AD patients [34], and null mutation in FLG is the strongest risk factor for AD [35].”
BackgroundTwo Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
Simpson, E. L., Bieber, T., Guttman-Yassky, E., Beck, L. A., Blauvelt, A., Cork, M. J., Silverberg, J. I., Deleuran, M., Kataoka, Y., Lacour, J.-P., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1610020 · Cited by 2,110 · cited 1×
“Moreover, a recent phase III study has confirmed the findings in a larger number of patients [184].”
ResultEndogenous Antimicrobial Peptides and Skin Infections in Atopic Dermatitis
Ong, P. Y., Ohtake, T., Brandt, C., Strickland, I., Boguniewicz, M., Ganz, T., Gallo, R. L., & Leung, D. Y. M. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021481 · Cited by 1,960
Weidinger, S., & Novak, N. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00149-x · Cited by 1,908
Kong, H. H., Oh, J., Deming, C., Conlan, S., Grice, E. A., Beatson, M. A., Nomicos, E., Polley, E. C., Komarow, H. D., Program, N. C. S., et al. (2012) · Genome Research · doi:10.1101/gr.131029.111 · Cited by 1,808 · cited 1×
“aureus colonization and/or infections with a loss of microbial diversity during flares [121].”
BackgroundBieber, T. (2008) · New England Journal of Medicine · doi:10.1056/nejmra074081 · Cited by 1,780
Claudin-based tight junctions are crucial for the mammalian epidermal barrier
Furuse, M., Hata, M., Furuse, K., Yoshida, Y., Haratake, A., Sugitani, Y., Noda, T., Kubo, A., & Tsukita, S. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200110122 · Cited by 1,512 · cited 1×
“The importance of TJs in barrier function has been clearly demonstrated: mice with claudin-1 deficiency die within a day after birth with wrinkling skin [28].”
BackgroundDupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis
Beck, L. A., Thaçi, D., Hamilton, J. D., Graham, N. M., Bieber, T., Rocklin, R., Ming, J. E., Ren, H., Kao, R., Simpson, E., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1314768 · Cited by 1,421 · cited 1×
“This subunit is shared by IL-4 and IL-13; therefore, by blocking IL-4Ra, both IL-4 and IL-13 are inhibited [181].”
BackgroundFilaggrin Mutations Associated with Skin and Allergic Diseases
Irvine, A. D., McLean, W. H. I., & Leung, D. Y. M. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1011040 · Cited by 1,217 · cited 3×
“On the contrary, a significant portion of AD patients do not have FLG mutation [36].”
BackgroundInfluentialCytokine modulation of atopic dermatitis filaggrin skin expression
Howell, M. D., Kim, B. E., Gao, P., Grant, A. V., Boguniewicz, M., DeBenedetto, A., Schneider, L., Beck, L. A., Barnes, K. C., & Leung, D. Y. M. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.04.031 · Cited by 1,084 · cited 1×
“FLG, loricrin, and involucrin, the integral components of SC, are downregulated with Th2 cytokines, regardless of FLG genotypes [101, 102].”
BackgroundInterleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice
Dillon, S. R., Sprecher, C., Hammond, A., Bilsborough, J., Rosenfeld-Franklin, M., Presnell, S. R., Haugen, H. S., Maurer, M., Harder, B., Johnston, J., et al. (2004) · Nature Immunology · doi:10.1038/ni1084 · Cited by 1,015 · cited 12×
“The IL-31 level is elevated in AD skin as well as in the serum [163, 171].”
BackgroundInfluentialIL-31: A new link between T cells and pruritus in atopic skin inflammation
Sonkoly, E., Muller, A., Lauerma, A. I., Pivarcsi, A., Soto, H., Kemeny, L., Alenius, H., Dieu-Nosjean, M.-C., Meller, S., Rieker, J., et al. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.10.033 · Cited by 1,005 · cited 12×
“The IL-31 level is elevated in AD skin as well as in the serum [163, 171].”
BackgroundInfluentialThe Epithelial Cell-Derived Atopic Dermatitis Cytokine TSLP Activates Neurons to Induce Itch
Wilson, S. R., Thé, L., Batia, L. M., Beattie, K., Katibah, G. E., McClain, S. P., Pellegrino, M., Estandian, D. M., & Bautista, D. M. (2013) · Cell · doi:10.1016/j.cell.2013.08.057 · Cited by 987 · cited 1×
“aureus [151]), substance P [63, 151], IL-31 [163, 164], TSLP [165], and endothelin-1 [166].”
BackgroundA role for IL-25 and IL-33–driven type-2 innate lymphoid cells in atopic dermatitis
Salimi, M., Barlow, J. L., Saunders, S. P., Xue, L., Gutowska-Owsiak, D., Wang, X., Huang, L.-C., Johnson, D., Scanlon, S. T., McKenzie, A. N. J., et al. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20130351 · Cited by 979 · cited 9×
“Barrier disruption leads to the al lymphopoietin (TSLP), IL-25, and IL-33.”
BackgroundInfluentialIkoma, A., Steinhoff, M., Ständer, S., Yosipovitch, G., & Schmelz, M. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1950 · Cited by 949 · cited 1×
“This hypersensitivity of the primary itch-sensing neurons may contribute to alloknesis, pruritus resulting from non-pruritogenic stimuli [158], which is a well-observed phenomenon in AD patients [159].”
BackgroundMutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome
Chavanas, S., Bodemer, C., Rochat, A., Hamel-Teillac, D., Ali, M., Irvine, A. D., Bonafé, J.-L., Wilkinson, J., Taïeb, A., Barrandon, Y., et al. (2000) · Nature Genetics · doi:10.1038/75977 · Cited by 856 · cited 1×
“Patients with this disease exhibit severe dermatitis, allergic rhinoconjunctivitis, asthma, and a high serum IgE level [60].”
BackgroundImmune surveillance in the skin: mechanisms and clinical consequences
Kupper, T. S., & Fuhlbrigge, R. C. (2004) · Nature Reviews Immunology · doi:10.1038/nri1310 · Cited by 805 · cited 1×
“In the skin, PRRs are found in keratinocytes and other innate immune cells [131] and are known to be involved in the pathogenesis of AD.”
BackgroundThe natural course of atopic dermatitis from birth to age 7 years and the association with asthma
Illi, S., von Mutius, E., Lau, S., Nickel, R., Grüber, C., Niggemann, B., Wahn, U., & the Multicenter Allergy Study Group (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.01.778 · Cited by 798
Tight junctions/adherens junctions: basic structure and function
Niessen, C. M. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700865 · Cited by 756 · cited 1×
“Zonula occludens (ZO) is the major cytosolic scaffolding proteins responsible for the TJ assembly [27].”
BackgroundTight junction defects in patients with atopic dermatitis
De Benedetto, A., Rafaels, N. M., McGirt, L. Y., Ivanov, A. I., Georas, S. N., Cheadle, C., Berger, A. E., Zhang, K., Vidyasagar, S., Yoshida, T., et al. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.10.018 · Cited by 747 · cited 2×
“In addition, polymorphisms of CLDN1-encoding claudin-1 are found in AD patients [29].”
BackgroundTSLP Elicits IL-33–Independent Innate Lymphoid Cell Responses to Promote Skin Inflammation
Kim, B. S., Siracusa, M. C., Saenz, S. A., Noti, M., Monticelli, L. A., Sonnenberg, G. F., Hepworth, M. R., Van Voorhees, A. S., Comeau, M. R., & Artis, D. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005374 · Cited by 731 · cited 4×
“Certain epithelial-derived cytokines and eicosanoids, namely, TSLP [71], IL-25 [73], IL-33 [73, 74], and prostaglandin D2 (PGD2) [75, 76], can activate ILC2 whereas Ecadherin [73] is known to have an inhibitory effect.”
BackgroundInfluentialPossible Pathogenic Role of Th17 Cells for Atopic Dermatitis
Koga, C., Kabashima, K., Shiraishi, N., Kobayashi, M., & Tokura, Y. (2008) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.111 · Cited by 671
Self-citationNoda, S., Suárez-Fariñas, M., Ungar, B., Kim, S. J., de Guzman Strong, C., Xu, H., Peng, X., Estrada, Y. D., Nakajima, S., Honda, T., et al. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.08.015 · Cited by 657 · cited 1×
“It is of note that higher Th17 activation is observed in Asian AD; this needs to be considered in the selection of treatments for different populations [120].”
BackgroundSelf-citationthe EArly Genetics and Lifecourse Epidemiology (EAGLE) Eczema Consortium (2015) · Nature Genetics · doi:10.1038/ng.3424 · Cited by 621 · cited 2×
“FLG is known to be decreased in the epidermis of AD patients [34], and null mutation in FLG is the strongest risk factor for AD [35].”
BackgroundFunctional Specializations of Human Epidermal Langerhans Cells and CD14+ Dermal Dendritic Cells
Klechevsky, E., Morita, R., Liu, M., Cao, Y., Coquery, S., Thompson-Snipes, L., Briere, F., Chaussabel, D., Zurawski, G., Palucka, A. K., et al. (2008) · Immunity · doi:10.1016/j.immuni.2008.07.013 · Cited by 619 · cited 1×
“LCs’ function in this regard has been reported to induce Th2 responses as LCs efficiently drive naïve CD4 T cells into Th2 cells [86].”
BackgroundYoo, J., Omori, M., Gyarmati, D., Zhou, B., Aye, T., Brewer, A., Comeau, M. R., Campbell, D. J., & Ziegler, S. F. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041503 · Cited by 613 · cited 1×
“Keratinocyte-derived cytokines such as TSLP [65], which is known to promote the AD-like phenotype [66], IL-25, IL-33, and granulocyte-macrophage colonystimulating factor (GM-CSF) influence innate lymphoid cells (ILCs) and increase the production of Th2 chemokines: CCL17 (thymus- and activation-regulated chemokine (TAR…”
BackgroundCellular and molecular immunologic mechanisms in patients with atopic dermatitis
Werfel, T., Allam, J.-P., Biedermann, T., Eyerich, K., Gilles, S., Guttman-Yassky, E., Hoetzenecker, W., Knol, E., Simon, H.-U., Wollenberg, A., et al. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.06.010 · Cited by 594 · cited 3×
“TSLP, IL-25, and IL-33 are upregulated in the epithelium after environmental signals [11].”
BackgroundPaller, A. S., Tom, W. L., Lebwohl, M. G., Blumenthal, R. L., Boguniewicz, M., Call, R. S., Eichenfield, L. F., Forsha, D. W., Rees, W. C., Simpson, E. L., et al. (2016) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2016.05.046 · Cited by 577 · cited 1×
“, crisaborole [194] and E6005 [195], demonstrate clinical efficacy for AD in phase II and III clinical trials, respectively.”
BackgroundThaçi, D., Simpson, E. L., Beck, L. A., Bieber, T., Blauvelt, A., Papp, K., Soong, W., Worm, M., Szepietowski, J. C., Sofen, H., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00388-8 · Cited by 572 · cited 1×
“Recently, a novel biological agent, the anti-IL-4 receptor antibody dupilumab, has been studied in clinical trials and found to be promising for the treatment of AD [107].”
BackgroundStaphylococcus δ-toxin induces allergic skin disease by activating mast cells
Nakamura, Y., Oscherwitz, J., Cease, K. B., Chan, S. M., Muñoz-Planillo, R., Hasegawa, M., Villaruz, A. E., Cheung, G. Y. C., McGavin, M. J., Travers, J. B., et al. (2013) · Nature · doi:10.1038/nature12655 · Cited by 558 · cited 1×
“aureus δ-toxin can stimulate mast cell degranulation [149].”
BackgroundLoricrin and involucrin expression is down-regulated by Th2 cytokines through STAT-6
Kim, B. E., Leung, D. Y. M., Boguniewicz, M., & Howell, M. D. (2008) · Clinical Immunology · doi:10.1016/j.clim.2007.11.006 · Cited by 538 · cited 1×
“FLG, loricrin, and involucrin, the integral components of SC, are downregulated with Th2 cytokines, regardless of FLG genotypes [101, 102].”
BackgroundOne remarkable molecule: filaggrin
Brown, S. J., & Irwin McLean, W. H. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.393 · Cited by 527 · cited 1×
“FLG is essential for controlling transepidermal water loss and maintaining SC hydration [31, 32] and for the cornification and organization of the epidermis [31, 33].”
BackgroundBeattie, P. E., & Lewis-Jones, M. S. (2006) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2006.07185.x · Cited by 526
Leung, D. Y., Harbeck, R., Bina, P., Reiser, R. F., Yang, E., Norris, D. A., Hanifin, J. M., & Sampson, H. A. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116711 · Cited by 519 · cited 16×
“In addition, a study that used a repeated hapten application to induce AD in mice showed that IL-17A is necessary for the development of skin inflammation, IL-4 production, and IgG1 and IgE induction [112].”
BackgroundInfluentialBriot, A., Deraison, C., Lacroix, M., Bonnart, C., Robin, A., Besson, C., Dubus, P., & Hovnanian, A. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20082242 · Cited by 504 · cited 1×
“Moreover, by binding to the proteaseactivated receptor type 2 (PAR2) on keratinocytes, KLKs can induce thymic stromal lymphopoietin (TSLP) production that further promotes inflammation [39, 40].”
BackgroundCutaneous immunosurveillance and regulation of inflammation by group 2 innate lymphoid cells
Roediger, B., Kyle, R., Yip, K. H., Sumaria, N., Guy, T. V., Kim, B. S., Mitchell, A. J., Tay, S. S., Jain, R., Forbes-Blom, E., et al. (2013) · Nature Immunology · doi:10.1038/ni.2584 · Cited by 492 · cited 3×
“increase in stimulatory but a decrease in inhibitory stimuli derived cytokines, IL-2 and IL-7 [72].”
BackgroundExternal antigen uptake by Langerhans cells with reorganization of epidermal tight junction barriers
Kubo, A., Nagao, K., Yokouchi, M., Sasaki, H., & Amagai, M. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20091527 · Cited by 491 · cited 1×
“LCs perform surface antigen surveillance and recognition by extending their dendrites through the TJs to take up the antigens [85].”
BackgroundSuárez-Fariñas, M., Dhingra, N., Gittler, J., Shemer, A., Cardinale, I., de Guzman Strong, C., Krueger, J. G., & Guttman-Yassky, E. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.04.046 · Cited by 483 · cited 1×
“Patients with intrinsic AD usually do not show an elevated IgE level, do not harbor FLG mutation, exhibit with an adult onset, and are associated with more Th17 and Th22 immune activation than extrinsic AD patients [119].”
BackgroundXue, L., Salimi, M., Panse, I., Mjösberg, J. M., McKenzie, A. N. J., Spits, H., Klenerman, P., & Ogg, G. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.10.056 · Cited by 475 · cited 3×
“PGD2, presumably from mast cell degranulation, also induction of ILC2 Th2 cytokine production.”
BackgroundFallon, P. G., Sasaki, T., Sandilands, A., Campbell, L. E., Saunders, S. P., Mangan, N. E., Callanan, J. J., Kawasaki, H., Shiohama, A., Kubo, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.358 · Cited by 473
Hamilton, J. D., Suárez-Fariñas, M., Dhingra, N., Cardinale, I., Li, X., Kostic, A., Ming, J. E., Radin, A. R., Krueger, J. G., Graham, N., et al. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.10.013 · Cited by 469
Wollenberg, A., Günther, S., Moderer, M., Wetzel, S., Wagner, M., Towarowski, A., Tuma, E., Rothenfusser, S., Endres, S., & Hartmann, G. (2002) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2002.19515.x · Cited by 461 · cited 1×
“Another interesting feature of AD is a decreased plasmacytoid DC (pDC) number in AD skin compared to that expected to be observed in skin inflammatory conditions [95].”
BackgroundImmunity against Staphylococcus aureus cutaneous infections
Miller, L. S., & Cho, J. S. (2011) · Nature Reviews Immunology · doi:10.1038/nri3010 · Cited by 434 · cited 2×
“aureus produces superantigens that also stimulate Th17 responses by increasing IL-17 production [140, 141].”
BackgroundImai, Y., Yasuda, K., Sakaguchi, Y., Haneda, T., Mizutani, H., Yoshimoto, T., Nakanishi, K., & Yamanishi, K. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1307321110 · Cited by 431 · cited 7×
“Barrier disruption leads to the al lymphopoietin (TSLP), IL-25, and IL-33.”
BackgroundInfluentialTopical tofacitinib for atopic dermatitis: a phase II a randomized trial
Bissonnette, R., Papp, K. A., Poulin, Y., Gooderham, M., Raman, M., Mallbris, L., Wang, C., Purohit, V., Mamolo, C., Papacharalambous, J., et al. (2016) · British Journal of Dermatology · doi:10.1111/bjd.14871 · Cited by 420 · cited 1×
“In addition, a greater percentage change from baseline (a reduction) in the EASI score was observed in a phase II clinical trial involving topical tofacitinib [203].”
BackgroundGene polymorphism in Netherton and common atopic disease
Walley, A. J., Chavanas, S., Moffatt, M. F., Esnouf, R. M., Ubhi, B., Lawrence, R., Wong, K., Abecasis, G. R., Jones, E. Y., Harper, J. I., et al. (2001) · Nature Genetics · doi:10.1038/ng728 · Cited by 401 · cited 1×
“Moreover, recent studies show that polymorphisms in SPINK5 are related to AD [61, 62].”
BackgroundCauses of epidermal filaggrin reduction and their role in the pathogenesis of atopic dermatitis
Thyssen, J. P., & Kezic, S. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.06.014 · Cited by 396 · cited 2×
“Additionally, a reduction in FLG predisposes microbial colonization in the skin [32], partly due to the loss of the acid mantle resulting from the decrease in FLG breakdown products [48] combined with the indirect neutralizing effects of FLG to α-toxin of Staphylococcus aureus [49].”
BackgroundIncreasing Comorbidities Suggest that Atopic Dermatitis Is a Systemic Disorder
Brunner, P. M., Silverberg, J. I., Guttman-Yassky, E., Paller, A. S., Kabashima, K., Amagai, M., Luger, T. A., Deleuran, M., Werfel, T., Eyerich, K., et al. (2017) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.08.022 · Cited by 377 · cited 1×
“Moreover, there are increasing evidence that AD is associated with systemic diseases and may be considered as a systemic disorder [9, 10].”
BackgroundSelf-citationKabashima, K. (2013) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2013.02.001 · Cited by 361 · cited 6×
“ILC2, characterized by having the transcription factor GATA3 and producing Th2 cytokines (IL-4, IL-5, and IL-13), is considered to be important in the pathogenesis of AD.”
BackgroundSelf-citationMediators of Chronic Pruritus in Atopic Dermatitis: Getting the Itch Out?
Mollanazar, N. K., Smith, P. K., & Yosipovitch, G. (2016) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-015-8488-5 · Cited by 353 · cited 18×
“In turn, Th2 cytokines IL-4 and IL-13 can induce keratinocytes to express TSLP [100].”
BackgroundInfluentialExtrinsic and intrinsic types of atopic dermatitis
Tokura, Y. (2010) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2010.02.008 · Cited by 349
Hirota, T., Takahashi, A., Kubo, M., Tsunoda, T., Tomita, K., Sakashita, M., Yamada, T., Fujieda, S., Tanaka, S., Doi, S., et al. (2012) · Nature Genetics · doi:10.1038/ng.2438 · Cited by 346 · cited 1×
“In fact, recent genome-wide association studies reported ten new loci that are associated with AD and show a relationship with autoimmune regulation, especially in innate signaling and T cell activation [35, 64].”
BackgroundNOD2/CARD15 Mediates Induction of the Antimicrobial Peptide Human Beta-defensin-2
Voss, E., Wehkamp, J., Wehkamp, K., Stange, E. F., Schröder, J. M., & Harder, J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511044200 · Cited by 344 · cited 1×
“aureus peptidoglycan is recognized by NOD2, NLR family, within keratinocytes [136].”
BackgroundToyoda, M., Nakamura, M., Makino, T., Hino, T., Kagoura, M., & Morohashi, M. (2002) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2002.04803.x · Cited by 339
Deraison, C., Bonnart, C., Lopez, F., Besson, C., Robinson, R., Jayakumar, A., Wagberg, F., Brattsand, M., Hachem, J. P., Leonardsson, G., et al. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-02-0124 · Cited by 329
Albanesi, C., Scarponi, C., Pallotta, S., Daniele, R., Bosisio, D., Madonna, S., Fortugno, P., Gonzalvo-Feo, S., Franssen, J.-D., Parmentier, M., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20080129 · Cited by 327 · cited 1×
“, chemerin, in AD skin [96] and a paucity of skin-homing molecules in the blood pDCs of AD patients [97] in combination with the Th2 milieu in the skin [84].”
BackgroundA Proteolytic Cascade of Kallikreins in the Stratum Corneum
Brattsand, M., Stefansson, K., Lundh, C., Haasum, Y., & Egelrud, T. (2005) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2004.23547.x · Cited by 326 · cited 1×
“FLG deficiency also leads to an increase in skin pH, which, in turn, enhances the function of serine proteases kallikrein (KLK)5, KLK7, and KLK14, which are responsible for corneocyte shedding [37].”
BackgroundBao, L., Zhang, H., & Chan, L. S. (2013) · JAK-STAT · doi:10.4161/jkst.24137 · Cited by 320 · cited 1×
“Furthermore, the activation of eosinophils, the maturation of B cells, and the suppression of regulatory T cells (Tregs) are mediated through the JAK-STAT signaling pathway [200].”
BackgroundSteinert, P. M., Cantieri, J. S., Teller, D. C., Lonsdale-Eccles, J. D., & Dale, B. A. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.7.4097 · Cited by 320 · cited 1×
“The term filaggrin is short for “filament-aggregating protein,” indicating that it is a protein that binds with keratin intermediate filaments and is responsible for the integral structural component [20].”
BackgroundPolarized in vivo expression of IL-11 and IL-17 between acute and chronic skin lesions
Toda, M., Leung, D. Y. M., Molet, S., Boguniewicz, M., Taha, R., Christodoulopoulos, P., Fukuda, T., Elias, J. A., & Hamid, Q. A. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2003.1414 · Cited by 306 · cited 1×
“Consistently, analysis of the peripheral blood of severe AD patients reveals an increased number of IL-17-producing cells [114, 115].”
BackgroundOyoshi, M. K., Larson, R. P., Ziegler, S. F., & Geha, R. S. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.08.041 · Cited by 304 · cited 3×
“Moreover, tape stripping also results in TSLP production in the skin [65].”
BackgroundAltered stratum corneum barrier and enhanced percutaneous immune responses in filaggrin-null mice
Kawasaki, H., Nagao, K., Kubo, A., Hata, T., Shimizu, A., Mizuno, H., Yamada, T., & Amagai, M. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.01.068 · Cited by 301 · cited 1×
“, Flg-null mice [45] and flaky tail mice [46], and augmented responses in contact hypersensitivity are detected [45].”
BackgroundCorrelation of IL-31 serum levels with severity of atopic dermatitis
Raap, U., Wichmann, K., Bruder, M., Ständer, S., Wedi, B., Kapp, A., & Werfel, T. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.05.047 · Cited by 299 · cited 1×
“The IL-31 serum level correlates with the disease severity [172].”
BackgroundEvidence for a streptococcal superantigen-driven process in acute guttate psoriasis.
Leung, D. Y., Travers, J. B., Giorno, R., Norris, D. A., Skinner, R., Aelion, J., Kazemi, L. V., Kim, M. H., Trumble, A. E., & Kotb, M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118263 · Cited by 295 · cited 1×
“Its toxic shock syndrome toxin 1 (TSST-1) and enterotoxins (SEs) act as superantigens to activate a large number of T cells [146], promote T cell recruitment to the skin [147], and exert superantigen-specific IgE [148].”
BackgroundMildner, M., Jin, J., Eckhart, L., Kezic, S., Gruber, F., Barresi, C., Stremnitzer, C., Buchberger, M., Mlitz, V., Ballaun, C., et al. (2010) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.115 · Cited by 291
IL-31 regulates differentiation and filaggrin expression in human organotypic skin models
Cornelissen, C., Marquardt, Y., Czaja, K., Wenzel, J., Frank, J., Lüscher-Firzlaff, J., Lüscher, B., & Baron, J. M. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.10.042 · Cited by 290 · cited 1×
“Upon its ligand binding, IL-31 signaling is mediated by activation of the JAK-signal transducer and activator of transcription (STAT) (STAT-1/5 and ERK-1/2), mitogenactivated protein kinase, and phosphoinositide-3-kinase (PI3K) signaling pathways [169, 170].”
BackgroundBrandner, J. M., Kief, S., Grund, C., Rendl, M., Houdek, P., Kuhn, C., Tschachler, E., Franke, W. W., & Moll, I. (2002) · European Journal of Cell Biology · doi:10.1078/0171-9335-00244 · Cited by 289 · cited 1×
“Networks of TJs are found in the intercellular spaces of SG and regulate the paracellular transport of water, ions, and solutes [19, 26].”
BackgroundScharschmidt, T. C., Man, M.-Q., Hatano, Y., Crumrine, D., Gunathilake, R., Sundberg, J. P., Silva, K. A., Mauro, T. M., Hupe, M., Cho, S., et al. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.06.046 · Cited by 287
Basophils Promote Innate Lymphoid Cell Responses in Inflamed Skin
Kim, B. S., Wang, K., Siracusa, M. C., Saenz, S. A., Brestoff, J. R., Monticelli, L. A., Noti, M., Tait Wojno, E. D., Fung, T. C., Kubo, M., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1401307 · Cited by 278 · cited 1×
“Importantly, IL-4 from basophils can directly activate ILC2 and bring about AD-like inflammation [77].”
BackgroundPersistence of Mild to Moderate Atopic Dermatitis
Margolis, J. S., Abuabara, K., Bilker, W., Hoffstad, O., & Margolis, D. J. (2014) · JAMA Dermatology · doi:10.1001/jamadermatol.2013.10271 · Cited by 276 · cited 1×
“However, many remain affected [13, 14], and some may experience a new disease onset in adulthood [1].”
BackgroundKezic, S., O’Regan, G. M., Lutter, R., Jakasa, I., Koster, E. S., Saunders, S., Caspers, P., Kemperman, P. M. J. H., Puppels, G. J., Sandilands, A., et al. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.12.989 · Cited by 273
The epidermal barrier function is dependent on the serine protease CAP1/Prss8
Leyvraz, C., Charles, R.-P., Rubera, I., Guitard, M., Rotman, S., Breiden, B., Sandhoff, K., & Hummler, E. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200501038 · Cited by 272 · cited 2×
“In addition, the derangement in proteases required for profilaggrin and Flg processing also gives rise to impairment of the skin barrier and SC dehydration, as observed in mice deficient in CAP1 [21], SASPase [22], and caspase 14 [24].”
BackgroundMortz, C. G., Andersen, K. E., Dellgren, C., Barington, T., & Bindslev‐Jensen, C. (2015) · Allergy · doi:10.1111/all.12619 · Cited by 267 · cited 1×
“However, many remain affected [13, 14], and some may experience a new disease onset in adulthood [1].”
BackgroundEgawa, G., & Kabashima, K. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.06.002 · Cited by 265 · cited 3×
“free fatty acids, and cholesterol in a ratio of 1:1:1 M [18].”
BackgroundSelf-citationAmano, W., Nakajima, S., Kunugi, H., Numata, Y., Kitoh, A., Egawa, G., Dainichi, T., Honda, T., Otsuka, A., Kimoto, Y., et al. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.03.051 · Cited by 259 · cited 4×
“The table is modified from Heratizadeh and Werfel [178], Lauffer and Ring [179], Noda et al. [180], Nomura and Kabashima [173], and Werfel et al. [11] Mechanism of action Route Compound Company Type of clinical trial Result Targeting pathogenic cytokines and their cognate receptors IL-4/IL-13 receptor α-chain antagoni…”
BackgroundSelf-citationHarder, J., Dressel, S., Wittersheim, M., Cordes, J., Meyer-Hoffert, U., Mrowietz, U., Fölster-Holst, R., Proksch, E., Schröder, J.-M., Schwarz, T., et al. (2010) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.432 · Cited by 259 · cited 2×
“An increase in S100 proteins in patients with AD has been reported [124, 125].”
BackgroundAnti-CD20 (rituximab) treatment improves atopic eczema
Simon, D., Hösli, S., Kostylina, G., Yawalkar, N., & Simon, H.-U. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.11.016 · Cited by 255
Arm, J. P., Bottoli, I., Skerjanec, A., Floch, D., Groenewegen, A., Maahs, S., Owen, C. E., Jones, I., & Lowe, P. J. (2014) · Clinical & Experimental Allergy · doi:10.1111/cea.12400 · Cited by 248 · cited 1×
“Ligelizumab, a new anti-IgE antibody that exhibits a stronger IgE inhibitory effect compared to that of omalizumab [211] may, however, be beneficial for AD and is currently in a phase II trial (NCT01552629).”
BackgroundOyoshi, M. K., Murphy, G. F., & Geha, R. S. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.05.042 · Cited by 245 · cited 1×
“Interestingly, IL-17A is detected in the AD-like dermatitis of flaky tail mice [42, 46, 113].”
BackgroundSouness, J. E., Aldous, D., & Sargent, C. (2000) · Immunopharmacology · doi:10.1016/s0162-3109(00)00185-5 · Cited by 244 · cited 1×
“Inhibition of PDE-4 resulted in an accumulation of intracellular cyclic adenosine monophosphate (cAMP), which in turn inhibits proinflammatory cytokine transcription and production [192].”
BackgroundNakajima, S., Igyártó, B. Z., Honda, T., Egawa, G., Otsuka, A., Hara-Chikuma, M., Watanabe, N., Ziegler, S. F., Tomura, M., Inaba, K., et al. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.01.063 · Cited by 243 · cited 2×
“demonstrated that LCs are essential to the induction of clinical manifestations and IgE elevation in a mouse model upon epicutaneous sensitization with the protein antigen ovalbumin (OVA) via the action of TSLP and its receptors presented on LCs [87].”
BackgroundSelf-citationEffect of filaggrin breakdown products on growth of and protein expression by Staphylococcus aureus
Miajlovic, H., Fallon, P. G., Irvine, A. D., & Foster, T. J. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.09.015 · Cited by 241 · cited 1×
“Additionally, a reduction in FLG predisposes microbial colonization in the skin [32], partly due to the loss of the acid mantle resulting from the decrease in FLG breakdown products [48] combined with the indirect neutralizing effects of FLG to α-toxin of Staphylococcus aureus [49].”
BackgroundAhmad-Nejad, P., Mrabet-Dahbi, S., Breuer, K., Klotz, M., Werfel, T., Herz, U., Heeg, K., Neumaier, M., & Renz, H. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2003.12.583 · Cited by 241
Grewe, S. R., Chan, S. C., & Hanifin, J. M. (1982) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(82)90008-2 · Cited by 230 · cited 1×
“It is also known that AD mononuclear leukocytes exhibit increased cAMP-PDE activity that leads to inflammation [193].”
BackgroundCzarnowicki, T., Gonzalez, J., Shemer, A., Malajian, D., Xu, H., Zheng, X., Khattri, S., Gilleaudeau, P., Sullivan-Whalen, M., Suárez-Fariñas, M., et al. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.01.020 · Cited by 221 · cited 1×
“Indeed, in AD patients with skin infections, a rise in the percentage of Th17 cells in peripheral blood has been found [142].”
BackgroundStoll, H., Dengjel, J., Nerz, C., & Götz, F. (2005) · Infection and Immunity · doi:10.1128/iai.73.4.2411-2423.2005 · Cited by 220 · cited 1×
“aureus [132] that has a unique ability to form either a homodimer or a heterodimer with TLR1 or TLR6 to expand their binding spectrum capability [133].”
BackgroundSTAT3-dependent reactive astrogliosis in the spinal dorsal horn underlies chronic itch
Shiratori-Hayashi, M., Koga, K., Tozaki-Saitoh, H., Kohro, Y., Toyonaga, H., Yamaguchi, C., Hasegawa, A., Nakahara, T., Hachisuka, J., Akira, S., et al. (2015) · Nature Medicine · doi:10.1038/nm.3912 · Cited by 218 · cited 1×
“results in the production of lipocalin-2 that enhances pruritus and may lead to a vicious itch-scratch cycle [176].”
BackgroundCaspase-14 Is Required for Filaggrin Degradation to Natural Moisturizing Factors in the Skin
Hoste, E., Kemperman, P., Devos, M., Denecker, G., Kezic, S., Yau, N., Gilbert, B., Lippens, S., De Groote, P., Roelandt, R., et al. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.153 · Cited by 216 · cited 2×
“In addition, the derangement in proteases required for profilaggrin and Flg processing also gives rise to impairment of the skin barrier and SC dehydration, as observed in mice deficient in CAP1 [21], SASPase [22], and caspase 14 [24].”
BackgroundGläser, R., Meyer-Hoffert, U., Harder, J., Cordes, J., Wittersheim, M., Kobliakova, J., Fölster-Holst, R., Proksch, E., Schröder, J.-M., & Schwarz, T. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.268 · Cited by 214 · cited 8×
“An increase in S100 proteins in patients with AD has been reported [124, 125].”
BackgroundInfluentialEfficacy and safety of ustekinumab treatment in adults with moderate‐to‐severe atopic dermatitis
Khattri, S., Brunner, P. M., Garcet, S., Finney, R., Cohen, S. R., Oliva, M., Dutt, R., Fuentes‐Duculan, J., Zheng, X., Li, X., et al. (2017) · Experimental Dermatology · doi:10.1111/exd.13112 · Cited by 214 · cited 1×
“Notably, a recent phase II study showed no significant differences in clinical efficacy (SCORAD50) between ustekinumab and placebo in adult AD patients, which may be explained by an inappropriate dosing regimen [185].”
BackgroundTait Wojno, E. D., Monticelli, L. A., Tran, S. V., Alenghat, T., Osborne, L. C., Thome, J. J., Willis, C., Budelsky, A., Farber, D. L., & Artis, D. (2015) · Mucosal Immunology · doi:10.1038/mi.2015.21 · Cited by 213 · cited 2×
“CRTh2 is a prostaglandin D2 receptor that is expressed in Th2 cells, ILC2, eosinophils, and basophils [197, 198].”
BackgroundHe, R., Oyoshi, M. K., Jin, H., & Geha, R. S. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706942104 · Cited by 205 · cited 1×
“For instance, it is reported that epicutaneous sensitization in mice with OVA typically leads to AD-like dermatitis and the cutaneous expression of IL-17 and IL-17-producing T cells in the draining lymph nodes and spleen, as well as increased serum IL-17 levels [111].”
BackgroundHruz, P., Zinkernagel, A. S., Jenikova, G., Botwin, G. J., Hugot, J.-P., Karin, M., Nizet, V., & Eckmann, L. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904958106 · Cited by 204 · cited 1×
“aureus infection [137], and polymorphisms in the NOD2 gene are associated with human AD [138].”
BackgroundThe translational revolution and use of biologics in patients with inflammatory skin diseases
Noda, S., Krueger, J. G., & Guttman-Yassky, E. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.11.015 · Cited by 198 · cited 1×
“[180], Nomura and Kabashima [173], and Werfel et al.”
Cutaneous nerves in atopic dermatitis
Urashima, R., & Mihara, M. (1998) · Virchows Archiv · doi:10.1007/s004280050179 · Cited by 193
Nemoto, O., Furue, M., Nakagawa, H., Shiramoto, M., Hanada, R., Matsuki, S., Imayama, S., Kato, M., Hasebe, I., Taira, K., et al. (2016) · British Journal of Dermatology · doi:10.1111/bjd.14207 · Cited by 193 · cited 1×
“Additionally, a result from a phase I/Ib study suggests that nemolizumab is well tolerated and seems to be beneficial, especially in alleviating troublesome pruritus [189].”
BackgroundSelf-citationJeong, S. K., Kim, H. J., Youm, J.-K., Ahn, S. K., Choi, E. H., Sohn, M. H., Kim, K.-E., Hong, J. H., Shin, D. M., & Lee, S. H. (2008) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.13 · Cited by 190 · cited 1×
“Allergen penetration results in inflammasome and protease activation [47].”
BackgroundNovak, N., Valenta, R., Bohle, B., Laffer, S., Haberstok, J., Kraft, S., & Bieber, T. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.02.005 · Cited by 189 · cited 6×
“A patch test study showed that IDECs rapidly migrate into the epidermis of patch-tested lesions [94].”
BackgroundInfluentialEbner, S., Nguyen, V. A., Forstner, M., Wang, Y.-H., Wolfram, D., Liu, Y.-J., & Romani, N. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.01.003 · Cited by 188 · cited 1×
“Importantly, TSLP can trigger DC migration to the draining lymph nodes [90], and LCs treated with TSLP drive naïve T cells to Th2 phenotypes [91].”
BackgroundInnate lymphoid cells in allergic and nonallergic inflammation
Morita, H., Moro, K., & Koyasu, S. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.09.011 · Cited by 186
The Histamine H4 Receptor Mediates Inflammation and Pruritus in Th2-Dependent Dermal Inflammation
Cowden, J. M., Zhang, M., Dunford, P. J., & Thurmond, R. L. (2010) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.358 · Cited by 180 · cited 2×
“Several itch mediators and their corresponding receptors are reported to be responsible for itch in AD: histamine (H), especially the role of H1 and H4 receptors (H1R and H4R) [157, 162], certain proteases (including tryptase, dust mites, and S.”
BackgroundAlduraywish, S. A., Lodge, C. J., Campbell, B., Allen, K. J., Erbas, B., Lowe, A. J., & Dharmage, S. C. (2016) · Allergy · doi:10.1111/all.12784 · Cited by 180
Ishiuji, Y., Coghill, R. C., Patel, T. S., Oshiro, Y., Kraft, R. A., & Yosipovitch, G. (2009) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2009.09308.x · Cited by 173 · cited 1×
“A study that used functional magnetic resonance imaging with arterial spin labelling, however, showed an increase in the activation of the anterior cingulate cortex and dorsolateral prefrontal cortex in human AD subjects compared with that of healthy controls [174].”
BackgroundFailure of omalizumab for treatment of severe adult atopic dermatitis
Krathen, R. A., & Hsu, S. (2005) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2005.02.014 · Cited by 172
Han, L., & Dong, X. (2014) · Annual Review of Biophysics · doi:10.1146/annurev-biophys-051013-022826 · Cited by 172 · cited 1×
“This hypersensitivity of the primary itch-sensing neurons may contribute to alloknesis, pruritus resulting from non-pruritogenic stimuli [158], which is a well-observed phenomenon in AD patients [159].”
BackgroundClinical Practice Guidelines for the Management of Atopic Dermatitis 2016
Saeki, H., Nakahara, T., Tanaka, A., Kabashima, K., Sugaya, M., Murota, H., Ebihara, T., Kataoka, Y., Aihara, M., Etoh, T., et al. (2016) · The Journal of Dermatology · doi:10.1111/1346-8138.13392 · Cited by 172 · cited 1×
“In summary, there are several promising therapies in the pipeline to satisfy the unmet needs of AD treatment [212].”
BackgroundSelf-citationKamata, Y., Taniguchi, A., Yamamoto, M., Nomura, J., Ishihara, K., Takahara, H., Hibino, T., & Takeda, A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m807908200 · Cited by 171 · cited 1×
“This degradation process is mediated by proteases, namely, caspase 14 [24], calpain 1 [25], and bleomycin hydrolase [25].”
BackgroundIL-17A as an Inducer for Th2 Immune Responses in Murine Atopic Dermatitis Models
Nakajima, S., Kitoh, A., Egawa, G., Natsuaki, Y., Nakamizo, S., Moniaga, C. S., Otsuka, A., Honda, T., Hanakawa, S., Amano, W., et al. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.51 · Cited by 169 · cited 1×
“In addition, a study that used a repeated hapten application to induce AD in mice showed that IL-17A is necessary for the development of skin inflammation, IL-4 production, and IgG1 and IgE induction [112].”
BackgroundSelf-citationMolecular Mechanisms of Cutaneous Inflammatory Disorder: Atopic Dermatitis
Kim, J. E., Kim, J., Cho, D., & Park, H. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17081234 · Cited by 167 · cited 2×
“In turn, Th2 cytokines IL-4 and IL-13 can induce keratinocytes to express TSLP [100].”
BackgroundPendaries, V., Malaisse, J., Pellerin, L., Lamer, M. L., Nachat, R., Kežić, S., Schmitt, A.-M., Paul, C. F., Poumay, Y., Serre, G., et al. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.259 · Cited by 165 · cited 1×
“FLG is essential for controlling transepidermal water loss and maintaining SC hydration [31, 32] and for the cornification and organization of the epidermis [31, 33].”
BackgroundTight junctions form a barrier in human epidermis
Kirschner, N., Houdek, P., Fromm, M., Moll, I., & Brandner, J. M. (2010) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2010.07.010 · Cited by 165 · cited 2×
“Networks of TJs are found in the intercellular spaces of SG and regulate the paracellular transport of water, ions, and solutes [19, 26].”
BackgroundNovak, N., Allam, J., Hagemann, T., Jenneck, C., Laffer, S., Valenta, R., Kochan, J. P., & Bieber, T. R. M. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.05.038 · Cited by 161 · cited 2×
“, chemerin, in AD skin [96] and a paucity of skin-homing molecules in the blood pDCs of AD patients [97] in combination with the Th2 milieu in the skin [84].”
BackgroundSaunders, S. P., Moran, T., Floudas, A., Wurlod, F., Kaszlikowska, A., Salimi, M., Quinn, E. M., Oliphant, C. J., Núñez, G., McManus, R., et al. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.06.045 · Cited by 160
Saunders, S. P., Goh, C. S. M., Brown, S. J., Palmer, C. N. A., Porter, R. M., Cole, C., Campbell, L. E., Gierlinski, M., Barton, G. J., Schneider, G., et al. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.08.046 · Cited by 160 · cited 2×
“Moreover, in the human counterpart, a meta-analysis revealed that a missense mutation in the human MATT gene is associated with AD [57].”
BackgroundSimpson, E. L., Gadkari, A., Worm, M., Soong, W., Blauvelt, A., Eckert, L., Wu, R., Ardeleanu, M., Graham, N. M. H., Pirozzi, G., et al. (2016) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2016.04.054 · Cited by 160
Low-dose anti-IgE therapy in patients with atopic eczema with high serum IgE levels
Belloni, B., Ziai, M., Lim, A., Lemercier, B., Sbornik, M., Weidinger, S., Andres, C., Schnopp, C., Ring, J., Hein, R., et al. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.08.060 · Cited by 157
Nygaard, U., Hvid, M., Johansen, C., Buchner, M., Fölster‐Holst, R., Deleuran, M., & Vestergaard, C. (2016) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.13679 · Cited by 157 · cited 11×
“It has been suggested that DCs initiate AD in humans, although it remains unclear which cutaneous DC subsets initiate epicutaneous sensitization.”
BackgroundInfluentialThe role of thymic stromal lymphopoietin (TSLP) in allergic disorders
Ziegler, S. F. (2010) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.10.020 · Cited by 154 · cited 1×
“TSLP is abundantly expressed in keratinocytes of lesional and non-lesional skin in AD patients as a result of both skin barrier dysfunction and proinflammatory cytokines, such as IL-1β, tumor necrosis factor (TNF)-α, IL-4, and IL-13 in AD [65, 89].”
BackgroundEfficacy of anti-IgE therapy in patients with atopic dermatitis
Vigo, P. G., Girgis, K. R., Pfuetze, B. L., Critchlow, M. E., Fisher, J., & Hussain, I. (2006) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2005.12.045 · Cited by 152
Kerschenlohr, K., Decard, S., Przybilla, B., & Wollenberg, A. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2003.1347 · Cited by 148 · cited 2×
“A patch test study showed that IDECs rapidly migrate into the epidermis of patch-tested lesions [94].”
BackgroundYuki, T., Tobiishi, M., Kusaka-Kikushima, A., Ota, Y., & Tokura, Y. (2016) · PLOS ONE · doi:10.1371/journal.pone.0161759 · Cited by 147 · cited 1×
“Importantly, TJ aberration is associated with AD since human AD epidermis has a reduced expression of claudin-1, claudin-23 [29], and ZO-1 [30] and shows evidence of impaired barrier function.”
BackgroundFornasa, G., Tsilingiri, K., Caprioli, F., Botti, F., Mapelli, M., Meller, S., Kislat, A., Homey, B., Di Sabatino, A., Sonzogni, A., et al. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.04.011 · Cited by 145 · cited 2×
“In the skin and gut, the short form is constitutively expressed, which is responsible for maintaining tissue homeostasis and acts as antimicrobial peptides [128, 129].”
BackgroundMoniaga, C. S., Egawa, G., Kawasaki, H., Hara‐Chikuma, M., Honda, T., Tanizaki, H., Nakajima, S., Otsuka, A., Matsuoka, H., Kubo, A., et al. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090957 · Cited by 142
Self-citationTominaga, M., Tengara, S., Kamo, A., Ogawa, H., & Takamori, K. (2009) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2009.03.007 · Cited by 136 · cited 1×
“An increase in nerve fiber density in the epidermis is reported in AD [153, 154].”
BackgroundUpregulation of Aquaporin-3 Is Involved in Keratinocyte Proliferation and Epidermal Hyperplasia
Nakahigashi, K., Kabashima, K., Ikoma, A., Verkman, A. S., Miyachi, Y., & Hara‐Chikuma, M. (2010) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.395 · Cited by 128 · cited 1×
“In addition to promoting Th2 cell recruitment, CCL17 has been reported to enhance keratinocyte proliferation and implicate in AD development [68].”
BackgroundSelf-citationSasaki, T., Shiohama, A., Kubo, A., Kawasaki, H., Ishida‐Yamamoto, A., Yamada, T., Hachiya, T., Shimizu, A., Okano, H., Kudoh, J., et al. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.08.027 · Cited by 127 · cited 2×
“Abnormality in Flg leads to an aberrant profilaggrin polypeptide expression while ma mutation gives rise to the matted hair and spontaneous dermatitis phenotype [41, 44].”
BackgroundCzarnowicki, T., Gonzalez, J., Bonifacio, K. M., Shemer, A., Xiangyu, P., Kunjravia, N., Malajian, D., Fuentes‐Duculan, J., Esaki, H., Noda, S., et al. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.08.027 · Cited by 126 · cited 1×
“Other possible biologics for AD that have been studied include drugs that target IgE and B cells, as an increase in B cells and IgE is commonly observed in AD patients [204].”
BackgroundDecreased production of semaphorin 3A in the lesional skin of atopic dermatitis
Tominaga, M., Ogawa, H., & Takamori, K. (2008) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2007.08410.x · Cited by 125 · cited 1×
“This is partly explained by the elevation of NGF that is observed in the plasma of AD patients [155] and a decrease in Sema3A that is detected in the lesional AD epidermis [156].”
BackgroundMoy, A. P., Murali, M. R., Kroshinsky, D., Duncan, L. M., & Nazarian, R. M. (2015) · JAMA Dermatology · doi:10.1001/jamadermatol.2015.2 · Cited by 123 · cited 16×
“In turn, Th2 cytokines IL-4 and IL-13 can induce keratinocytes to express TSLP [100].”
BackgroundInfluentialPolymorphisms in NACHT‐LRR (NLR) genes in atopic dermatitis
Macaluso, F., Nothnagel, M., Parwez, Q., Petrasch‐Parwez, E., Bechara, F. G., Epplen, J. T., & Hoffjan, S. (2007) · Experimental Dermatology · doi:10.1111/j.1600-0625.2007.00589.x · Cited by 123 · cited 1×
“aureus infection [137], and polymorphisms in the NOD2 gene are associated with human AD [138].”
BackgroundSASPase regulates stratum corneum hydration through profilaggrin‐to‐filaggrin processing
Matsui, T., Miyamoto, K., Kubo, A., Kawasaki, H., Ebihara, T., Hata, K., Tanahashi, S., Ichinose, S., Imoto, I., Inazawa, J., et al. (2011) · EMBO Molecular Medicine · doi:10.1002/emmm.201100140 · Cited by 123 · cited 2×
“In addition, the derangement in proteases required for profilaggrin and Flg processing also gives rise to impairment of the skin barrier and SC dehydration, as observed in mice deficient in CAP1 [21], SASPase [22], and caspase 14 [24].”
BackgroundEckl, K., de Juanes, S., Kurtenbach, J., Nätebus, M., Lugassy, J., Oji, V., Traupe, H., Preil, M., Martínez, F., Smolle, J., et al. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.409 · Cited by 122 · cited 1×
“For example, mutations of the genes that encode the enzymes 12R-lipoxygenase and epidermal lipoxygenase 3 are associated with autosomal recessive congenital ichthyosis (ARCI) [56].”
BackgroundQuality of life and disease severity in patients with atopic dermatitis
Holm, J. G., Agner, T., Clausen, M. ‐., & Thomsen, S. F. (2016) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.13689 · Cited by 120
Intraepidermal nerve fibers increase in dry skin of acetone-treated mice
Tominaga, M., Ozawa, S., Tengara, S., Ogawa, H., & Takamori, K. (2007) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2007.06.003 · Cited by 119 · cited 1×
“On the other hand, in dry skin model mice, epidermal barrier dysfunction is observed together with an increase in the number of epidermal nerve fibers [177].”
Background[CLINICAL PRACTICE GUIDELINES FOR THE MANAGEMENT OF ATOPIC DERMATITIS 2018].
Ebihara, T. (2021) · PubMed · doi:10.15036/arerugi.70.1186 · Cited by 119
Volz, T., Nega, M., Buschmann, J., Kaesler, S., Guenova, E., Peschel, A., Röcken, M., Götz, F., & Biedermann, T. (2010) · The FASEB Journal · doi:10.1096/fj.09-151001 · Cited by 114 · cited 1×
“aureus induces signaling through NOD-2 coupled with TLR stimulation which efficiently induces DCs to produce IL-12p70 and IL-23, which drive Th1 and Th17 responses, respectively [139].”
BackgroundEwald, D. A., Noda, S., Oliva, M., Litman, T., Nakajima, S., Li, X., Xu, H., Workman, C. T., Scheipers, P., Svitacheva, N., et al. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.08.029 · Cited by 114
Self-citationCommensal bacteria and cutaneous immunity
Nakamizo, S., Egawa, G., Honda, T., Nakajima, S., Belkaid, Y., & Kabashima, K. (2014) · Seminars in Immunopathology · doi:10.1007/s00281-014-0452-6 · Cited by 111 · cited 1×
“These summarized events eventually deteriorate the disease state of AD [150].”
BackgroundSelf-citationOtsuka, A., Doi, H., Egawa, G., Maekawa, A., Fujita, T., Nakamizo, S., Nakashima, C., Nakajima, S., Watanabe, T., Miyachi, Y., et al. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.07.027 · Cited by 111 · cited 1×
“Intriguingly, by promoting Flg expression in NC/Nga mice, development of the AD phenotype in the mice is attenuated, and upregulating FLG may be one of the approaches to improve AD [52].”
BackgroundSelf-citationStaphylococcus aureus Extracellular Protease Causes Epidermal Barrier Dysfunction
Hirasawa, Y., Takai, T., Nakamura, T., Mitsuishi, K., Gunawan, H., Suto, H., Ogawa, T., Wang, X., Ikeda, S., Okumura, K., et al. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.257 · Cited by 111 · cited 1×
“aureus can worsen barrier impairment [143]; releases proteases, enzymes, and cytolytic toxins that induce cell injuries [143, 144]; and engages PRRs and exerts inflammation [145].”
BackgroundDistribution of IL-31 and its receptor expressing cells in skin of atopic dermatitis
Kato, A., Fujii, E., Watanabe, T., Takashima, Y., Matsushita, H., Furuhashi, T., & Morita, A. (2014) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2014.02.009 · Cited by 110 · cited 1×
“IL-31 is predominantly produced by Th2 cells, and its receptor, which comprises IL-31 receptor α (IL-31RA) and oncostatin M receptor β (OSMRβ), is expressed in peripheral nerve fibers, dorsal root ganglions (DRGs), and keratinocytes [167, 168].”
BackgroundKabashima‐Kubo, R., Nakamura, M., Sakabe, J., Sugita, K., Hino, R., Mori, T., Kobayashi, M., Bito, T., Kabashima, K., Ogasawara, K., et al. (2012) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2012.04.004 · Cited by 108
Self-citationThe skin surface as antimicrobial barrier: present concepts and future outlooks
Harder, J., Schröder, J., & Gläser, R. (2013) · Experimental Dermatology · doi:10.1111/exd.12046 · Cited by 107 · cited 1×
“Upon challenges with danger signals/organisms, additional AMPs, namely, human beta-defensins (hBD)-2, hBD-3 and cathelicidin (LL-37), are upregulated [122].”
BackgroundMurota, H., Izumi, M., El-latif, M. I. A., Nishioka, M., Terao, M., Tani, M., Matsui, S., Sano, S., & Katayama, I. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.05.027 · Cited by 107 · cited 1×
“Interestingly, artemin, a glial cell-derived neurotrophic factor (GDNF)related family, is reported to be important in warm inducing itch because artemin is upregulated in fibroblasts from AD lesions, and an intradermal injection of artemin in mice leads to an increased number and sprouting of peripheral nerves togethe…”
BackgroundMrabet‐Dahbi, S., Dalpke, A. H., Niebuhr, M., Frey, M., Draing, C., Brand, S., Heeg, K. M., Werfel, T., & Renz, H. E. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.11.029 · Cited by 106
Moniaga, C. S., Jeong, S. K., Egawa, G., Nakajima, S., Hara‐Chikuma, M., Jeon, J. E., Lee, S. H., Hibino, T., Miyachi, Y., & Kabashima, K. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.11.039 · Cited by 105 · cited 1×
“Moreover, by binding to the proteaseactivated receptor type 2 (PAR2) on keratinocytes, KLKs can induce thymic stromal lymphopoietin (TSLP) production that further promotes inflammation [39, 40].”
BackgroundSelf-citationBjerkan, L., Schreurs, O., Engen, S. A., Jahnsen, F. L., Bækkevold, E. S., Blix, I. J., & Schenck, K. (2014) · Mucosal Immunology · doi:10.1038/mi.2014.41 · Cited by 105
An update on the role of human dendritic cells in patients with atopic dermatitis
Novak, N. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.01.062 · Cited by 104 · cited 3×
“During the inflammatory state of AD, myeloid inflammatory DCs, namely, inflammatory dendritic epidermal cells (IDECs), are recruited [92].”
BackgroundBrüggen, M., Bauer, W. M., Reininger, B., Clim, E., Captarencu, C., Steiner, G., Brunner, P. M., Meier-Schiesser, B., French, L. E., & Stingl, G. (2016) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.07.017 · Cited by 104 · cited 1×
“Several studies have shown that, although few ILCs are observed in normal human skin, in AD, the skin is infiltrated markedly by the ILC2 subset [70, 71].”
BackgroundDainichi, T., Hanakawa, S., & Kabashima, K. (2014) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2014.08.010 · Cited by 101
Self-citationNeural peptidase endothelin-converting enzyme 1 regulates endothelin 1–induced pruritus
Kido‐Nakahara, M., Buddenkotte, J., Kempkes, C., Ikoma, A., Cevikbas, F., Akiyama, T., Nunes, F., Seeliger, S., Hasdemir, B., Meß, C., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci67323 · Cited by 100 · cited 1×
“aureus [151]), substance P [63, 151], IL-31 [163, 164], TSLP [165], and endothelin-1 [166].”
BackgroundIncreased levels of serum IL‐31 in chronic spontaneous urticaria*
Raap, U., Wieczorek, D., Gehring, M., Pauls, I., Ständer, S., Kapp, A., & Wedi, B. (2010) · Experimental Dermatology · doi:10.1111/j.1600-0625.2010.01067.x · Cited by 93 · cited 1×
“The IL-31 level is elevated in AD skin as well as in the serum [163, 171].”
BackgroundKido‐Nakahara, M., Furue, M., Ulzii, D., & Nakahara, T. (2016) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2016.08.007 · Cited by 93
Anti-CD20 (rituximab) treatment for atopic eczema
Šedivá, A., Kayserová, J., Vernerová, E., Poloučková, A., Čapková, Š., Špíšek, R., & Bartůňková, J. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.03.007 · Cited by 89
Basophils regulate the recruitment of eosinophils in a murine model of irritant contact dermatitis
Nakashima, C., Otsuka, A., Kitoh, A., Honda, T., Egawa, G., Nakajima, S., Nakamizo, S., Arita, M., Kubo, M., Miyachi, Y., et al. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.02.026 · Cited by 88
Self-citation(2012) · PubMed · Cited by 88
Iwasaki, M., Nagata, K., Takano, S., Takahashi, K., Ishii, N., & Ikezawa, Z. (2002) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2002.01862.x · Cited by 86 · cited 1×
“CRTh2 is a prostaglandin D2 receptor that is expressed in Th2 cells, ILC2, eosinophils, and basophils [197, 198].”
BackgroundChan, S. C., Reifsnyder, D. H., Beavo, J. A., & Hanifin, J. M. (1993) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(93)90321-6 · Cited by 85 · cited 1×
“PDE is a crucial regulator of cytokine production, and PDE-4 is the most abundant isoenzyme found in human leukocytes [190].”
BackgroundElentner, A., Finke, D., Schmuth, M., Chappaz, S., Ebner, S., Malissen, B., Kissenpfennig, A., Romani, N., & Dubrac, S. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00797.x · Cited by 83 · cited 1×
“LCs are also responsible for the initiation of AD under the influence of TSLP [63, 87, 88].”
BackgroundOnoue, A., Kabashima, K., Kobayashi, M., Mori, T., & TOKURA, Y. (2009) · Experimental Dermatology · doi:10.1111/j.1600-0625.2009.00899.x · Cited by 82 · cited 2×
“, in an experimental tape stripping procedure, Th2 chemokines (CCL17 and CCL22) and eosinophil-recruiting chemokines (CCL5) are increasingly produced by keratinocytes [67].”
BackgroundSelf-citationInnate Lymphoid Cells in the Skin
Kim, B. S. (2015) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.401 · Cited by 81 · cited 1×
“ILCs are a novel group of innate immune cells developed from a common lymphoid progenitor [69].”
BackgroundCurrent Topical and Systemic Therapies for Itch
Leslie, T. A., Greaves, M. W., & Yosipovitch, G. (2015) · Handbook of experimental pharmacology · doi:10.1007/978-3-662-44605-8_18 · Cited by 78 · cited 1×
“This is evident in AD, as several psychotropic drugs, including antidepressants, can attenuate the itch severity in some patients [175].”
BackgroundMurota, H., Matsui, S., Ono, E., Kijima, A., Kikuta, J., Ishii, M., & Katayama, I. (2015) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2014.08.011 · Cited by 78 · cited 1×
“Sweating is known to be attenuated in AD, which may be a result of acrosyringium obstruction caused by abnormalities in the sweat duct structures and/or derangement in the common sudomotor nerves that control sweating [53, 54].”
BackgroundMast cells and basophils in cutaneous immune responses
Otsuka, A., & Kabashima, K. (2014) · Allergy · doi:10.1111/all.12526 · Cited by 77
Self-citationBrauweiler, A. M., Bin, L., Kim, B. E., Oyoshi, M. K., Geha, R. S., Goleva, E., & Leung, D. Y. M. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.10.030 · Cited by 76 · cited 1×
“Additionally, a reduction in FLG predisposes microbial colonization in the skin [32], partly due to the loss of the acid mantle resulting from the decrease in FLG breakdown products [48] combined with the indirect neutralizing effects of FLG to α-toxin of Staphylococcus aureus [49].”
BackgroundMori, T., Ishida, K., Mukumoto, S., Yamada, Y., Imokawa, G., Kabashima, K., Kobayashi, M., Bito, T., Nakamura, M., Ogasawara, K., et al. (2010) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2009.09440.x · Cited by 74
Self-citationFelding, J., Sørensen, M. D., Poulsen, T. D., Larsen, J., Andersson, C., Refer, P., Engell, K., Ladefoged, L. G., Thormann, T., Vinggaard, A. M., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500378a · Cited by 73 · cited 7×
“The table is modified from Heratizadeh and Werfel [178], Lauffer and Ring [179], Noda et al. [180], Nomura and Kabashima [173], and Werfel et al. [11] Mechanism of action Route Compound Company Type of clinical trial Result Targeting pathogenic cytokines and their cognate receptors IL-4/IL-13 receptor α-chain antagoni…”
BackgroundInfluentialJin, S., Park, C. O., Shin, J. U., Noh, J. Y., Lee, Y. S., Lee, N. R., Kim, H. R., Noh, S., Lee, Y., Lee, J., et al. (2014) · Experimental Dermatology · doi:10.1111/exd.12563 · Cited by 72 · cited 1×
“expression, which are responsible for eosinophil- and neutrophil-mediated inflammation [109, 110].”
BackgroundHattori, K., Nishikawa, M., Watcharanurak, K., Ikoma, A., Kabashima, K., Toyota, H., Takahashi, Y., Takahashi, R., Watanabe, Y., & Takakura, Y. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0900215 · Cited by 69
Self-citationThe panoply of αβT cells in the skin
Nomura, T., Kabashima, K., & Miyachi, Y. (2014) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2014.07.010 · Cited by 68
Self-citationAssociation of SPINK5 gene polymorphisms with atopic dermatitis in Northeast China
Zhao, L. P., Di, Z., Zhang, L., Wang, L., Ma, L., Lv, Y., Hong, Y., Wei, H., Chen, H. D., & Gao, X. H. (2012) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2011.04120.x · Cited by 66 · cited 1×
“Moreover, recent studies show that polymorphisms in SPINK5 are related to AD [61, 62].”
BackgroundHepburn, L., Hijnen, D., Sellman, B. R., Mustelin, T., Sleeman, M. A., May, R. D., & Strickland, I. (2016) · British Journal of Dermatology · doi:10.1111/bjd.15139 · Cited by 65 · cited 1×
“aureus can worsen barrier impairment [143]; releases proteases, enzymes, and cytolytic toxins that induce cell injuries [143, 144]; and engages PRRs and exerts inflammation [145].”
BackgroundThe Antimicrobial Skin Barrier in Patients with Atopic Dermatitis
Schittek, B. (2011) · Current problems in dermatology · doi:10.1159/000323296 · Cited by 62 · cited 2×
“These productions may not be sufficient to tackle the infections or the AMP functions may be disturbed [126].”
BackgroundIslander, U., Andersson, A., Lindberg, E., Adlerberth, I., Wold, A. E., & Rudin, A. (2009) · Infection and Immunity · doi:10.1128/iai.00724-09 · Cited by 61 · cited 1×
“aureus produces superantigens that also stimulate Th17 responses by increasing IL-17 production [140, 141].”
BackgroundAdvances in atopic dermatitis in 2015
Nomura, T., & Kabashima, K. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.10.004 · Cited by 60
Self-citationJanus kinase (JAK) inhibitors for the treatment of skin and hair disorders: a review of literature
Samadi, A., Nasrollahi, S. A., Hashemi, A., Kashani, M. N., & Firooz, A. (2016) · Journal of Dermatological Treatment · doi:10.1080/09546634.2016.1277179 · Cited by 58 · cited 1×
“JAK inhibitors have been investigated as a treatment for psoriasis and alopecia totalis [202].”
BackgroundAtopic Dermatitis/Atopic Eczema
Wallach, D., & Taïeb, A. (2014) · Chemical Immunology and Allergy · doi:10.1159/000358606 · Cited by 57
Nakai, K., Yoneda, K., Hosokawa, Y., Moriue, T., Presland, R. B., Fallon, P. G., Kabashima, K., Kosaka, H., & Kubota, Y. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.06.005 · Cited by 55 · cited 3×
“In addition, FLG deficiency that leads to a reduction in E-cadherin [73, 78] together with an increase in IL-4 derived from basophils and PGD2 from mast cells is present.”
BackgroundSelf-citationMost Highly Cytokinergic IgEs Have Polyreactivity to Autoantigens
Kashiwakura, J., Okayama, Y., Furue, M., Kabashima, K., Shimada, S., Ra, C., Siraganian, R. P., Kawakami, Y., & Kawakami, T. (2012) · Allergy Asthma and Immunology Research · doi:10.4168/aair.2012.4.6.332 · Cited by 54
Self-citationInhibitory effects of UV-based therapy on dry skin-inducible nerve growth in acetone-treated mice
Kamo, A., Tominaga, M., Tengara, S., Ogawa, H., & Takamori, K. (2011) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2011.01.004 · Cited by 53 · cited 1×
“, semaphorin 3A (Sema3A) and anosmin-1 [152].”
Antagonists of the Prostaglandin D2 Receptor CRTH2
Pettipher, R., & Hansel, T. T. (2008) · Drug News & Perspectives · doi:10.1358/dnp.2008.21.6.1246831 · Cited by 51 · cited 1×
“Activation of CRTh2 induces Th2 cell, ILC2, and eosinophil chemotaxis and promotes their cytokine production [197, 199].”
BackgroundMori, T., Kabashima, K., Fukamachi, S., Kuroda, E., Sakabe, J., Kobayashi, M., Nakajima, S., Nakano, K., Tanaka, Y., Matsushita, S., et al. (2013) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2013.03.008 · Cited by 51 · cited 1×
“ligand binding, mast cells are degranulated and Th2 cells are activated, observed by an increase in the ratio of IL-4 to IFN-γ mRNA expression [83].”
BackgroundSelf-citationAnti‐inflammatory therapies in atopic dermatitis
Heratizadeh, A., & Werfel, T. (2016) · Allergy · doi:10.1111/all.13065 · Cited by 50 · cited 3×
“The table is modified from Heratizadeh and Werfel [178], Lauffer and Ring [179], Noda et al. [180], Nomura and Kabashima [173], and Werfel et al. [11] Mechanism of action Route Compound Company Type of clinical trial Result Targeting pathogenic cytokines and their cognate receptors IL-4/IL-13 receptor α-chain antagoni…”
BackgroundMethodSon, E. D., Kim, H., Kim, K. H., Bin, B. H., Bae, I., Lim, K., Yu, S. J., Cho, E., & Lee, T. R. (2016) · Experimental Dermatology · doi:10.1111/exd.13023 · Cited by 48
Linking air pollution to atopic dermatitis
Kabashima, K., Otsuka, A., & Nomura, T. (2017) · Nature Immunology · doi:10.1038/ni.3615 · Cited by 47
Self-citationThe human cytokine TSLP triggers a cell-autonomous dendritic cell migration in confined environments
Fernandez, M.-I., Heuzé, M. L., Martínez-Cingolani, C., Volpe, E., Donnadieu, M., Piel, M., Homey, B., Lennon‐Duménil, A., & Soumelis, V. (2011) · Blood · doi:10.1182/blood-2010-12-323089 · Cited by 46 · cited 1×
“Importantly, TSLP can trigger DC migration to the draining lymph nodes [90], and LCs treated with TSLP drive naïve T cells to Th2 phenotypes [91].”
BackgroundHeise, R., Neis, M. M., Marquardt, Y., Joussen, S., Heinrich, P. C., Merk, H. F., Hermanns, H. M., & Baron, J. M. (2008) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.183 · Cited by 45 · cited 1×
“IL-31 is predominantly produced by Th2 cells, and its receptor, which comprises IL-31 receptor α (IL-31RA) and oncostatin M receptor β (OSMRβ), is expressed in peripheral nerve fibers, dorsal root ganglions (DRGs), and keratinocytes [167, 168].”
BackgroundSpaulding, A. R., Satterwhite, E. A., Lin, Y.-C., Chuang-Smith, O. N., Frank, K. L., Merriman, J. A., Schaefers, M. M., Yarwood, J. M., Peterson, M. L., & Schlievert, P. M. (2012) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2012.00018 · Cited by 45 · cited 1×
“Its toxic shock syndrome toxin 1 (TSST-1) and enterotoxins (SEs) act as superantigens to activate a large number of T cells [146], promote T cell recruitment to the skin [147], and exert superantigen-specific IgE [148].”
BackgroundEvolving understanding on the aetiology of thermally provoked itch
Murota, H., & Katayama, I. (2015) · European Journal of Pain · doi:10.1002/ejp.777 · Cited by 45 · cited 1×
“Interestingly, artemin, a glial cell-derived neurotrophic factor (GDNF)related family, is reported to be important in warm inducing itch because artemin is upregulated in fibroblasts from AD lesions, and an intradermal injection of artemin in mice leads to an increased number and sprouting of peripheral nerves togethe…”
BackgroundMatsui, S., Murota, H., Takahashi, A., Yang, L., Lee, J., Omiya, K., Ohmi, M., Kikuta, J., Ishii, M., & Katayama, I. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.323 · Cited by 44 · cited 1×
“Sweating is known to be attenuated in AD, which may be a result of acrosyringium obstruction caused by abnormalities in the sweat duct structures and/or derangement in the common sudomotor nerves that control sweating [53, 54].”
BackgroundOhba, F., Matsuki, S., Imayama, S., Matsuguma, K., Hojo, S., Nomoto, M., & Akama, H. (2016) · Journal of Dermatological Treatment · doi:10.3109/09546634.2016.1157257 · Cited by 44 · cited 3×
“Topical PDE-4 inhibitors, e.g., crisaborole [194] and E6005 [195], demonstrate clinical efficacy for AD in phase II and III clinical trials, respectively.”
BackgroundPonte, P., & Lopes, M. J. P. (2010) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2009.05.015 · Cited by 43
Target-oriented therapy: Emerging drugs for atopic dermatitis
Lauffer, F., & Ring, J. (2016) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2016.1146681 · Cited by 43 · cited 4×
“IL-23, which are required for the development and maintenance of Th17 and Th1 cells [179].”
BackgroundMethodInfluentialEffects of cyclosporine on pruritus and serum IL-31 levels in patients with atopic dermatitis
Otsuka, A., Tanioka, M., Nakagawa, Y., Honda, T., Ikoma, A., Miyachi, Y., & Kabashima, K. (2011) · European Journal of Dermatology · doi:10.1684/ejd.2011.1470 · Cited by 42 · cited 1×
“IL-31 is an important mediator of both itch and inflammation [186, 187].”
BackgroundSelf-citationKasraie, S., Niebuhr, M., & Werfel, T. (2013) · Allergy · doi:10.1111/all.12152 · Cited by 42 · cited 1×
“Upon its ligand binding, IL-31 signaling is mediated by activation of the JAK-signal transducer and activator of transcription (STAT) (STAT-1/5 and ERK-1/2), mitogenactivated protein kinase, and phosphoinositide-3-kinase (PI3K) signaling pathways [169, 170].”
BackgroundSkabytska, Y., Kaesler, S., Volz, T., & Biedermann, T. (2015) · Seminars in Immunopathology · doi:10.1007/s00281-015-0544-y · Cited by 42 · cited 2×
“dominated to Th1/Th17-co-dominated inflammation in the chronic stage of AD where multiple PRRs are engaged [133].”
Background
Cited by
Pathophysiology of atopic dermatitis: Clinical implications
Kim, J., Kim, B. E., & Leung, D. Y. M. (2019) · Allergy and Asthma Proceedings · doi:10.2500/aap.2019.40.4202 · Cited by 635
“A subset of sensory neurons that express histamine H1 receptor and histamine H4 receptor is activated by histamine, which can cause itch as well as allergic inflammation.(57) H1 antihistamines have been widely used for the treatment of itch due to urticaria, but its effects are limited in the treatment of chronic itch…”
BackgroundAtopic dermatitis: an expanding therapeutic pipeline for a complex disease
Bieber, T. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00266-6 · Cited by 623
Type 2 immunity in the skin and lungs
Akdis, C. A., Arkwright, P. D., Brüggen, M.-C., Busse, W., Gadina, M., Guttman‐Yassky, E., Kabashima, K., Mitamura, Y., Vian, L., Wu, J., et al. (2020) · Allergy · doi:10.1111/all.14318 · Cited by 560
Self-citationType 2 immunity in allergic diseases
Ogulur, I., Mitamura, Y., Yazici, D., Pat, Y., Ardicli, S., Li, M., D’Avino, P., Beha, C., Babayev, H., Zhao, B., et al. (2025) · Cellular & Molecular Immunology · doi:10.1038/s41423-025-01261-2 · Cited by 362
Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis
Silverberg, J. I., Guttman-Yassky, E., Thaçi, D., Irvine, A. D., Stein Gold, L., Blauvelt, A., Simpson, E. L., Chu, C.-Y., Liu, Z., Gontijo Lima, R., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2206714 · Cited by 345
Metadata
- Authors
- Rerknimitr, P., Otsuka, A., Nakashima, C., & Kabashima, K.
- Affiliations
- Chulalongkorn University (TH)
- Kyoto University (JP)
- Agency for Science, Technology and Research (SG)
- Corresponding author
- Otsuka, Atsushi
- Kabashima, Kenji
- Venue
- Inflammation and Regeneration
- Published
- 2017-06-05
- Volume
- 37
- Issue
- 1
- Pages
- 14-14
- ISSN
- 1346-8022 (ISSN-L)
- 1880-8190
- PMC
- PMC5725646
- OpenAlex
- W2623738179
- Cited by
- 187
- References
- 215
- Citations by year
- 2026: 15 · 2025: 21 · 2024: 29 · 2023: 18 · 2022: 19 · 2021: 30 · 2020: 21 · 2019: 22 · 2018: 12
- FWCI
- 2.69
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Inflammation and Regeneration (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Ministries of Education, Culture, Sports, Science and Technology
- the Japan Agency for Medical Research and Development (AMED)
- Ministry of Health, Labour and Welfare Sciences
- Topics
- Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
- Health Sciences › Medicine › Dermatology › Contact Dermatitis and Allergies
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Keywords
- atopic dermatitis, etiopathogenesis, skin barrier dysfunction, filaggrin, stratum corneum, tight junctions, pruritus, central sensitization, pruritogens, skin inflammation, biologic therapy, targeted therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.